Fei, Zhaodong
Xu, Ting
Hong, Huiling
Xu, Yiying
Chen, Jiawei
Qiu, Xiufang
Ding, Jianming
Huang, Chaoxiong
Li, Li
Liu, Jing
Chen, Chuanben
Funding for this research was provided by:
the Natural Science Foundation of Fujian Province (2020J011124)
Bethune-Translational Medicine Research Fund for Oncology radiotherapy (flzh202126)
Article History
Received: 28 July 2022
Accepted: 15 February 2023
First Online: 22 February 2023
Declarations
:
: The study was approved by the Ethical Committee of Fujian Cancer Hospital (YKT2020-011–01).
: Not required.
: The authors declare no competing interests.